Follow
Audrey Cantin
Audrey Cantin
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
Commissioning of an intra-operative US guided prostate HDR system integrating an EM tracking technology
MC Lavallée, A Cantin, F Monéger, M Lefebvre, W Foster, E Vigneault, ...
Brachytherapy 20 (6), 1296-1304, 2021
102021
Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation
A Cantin, L Gingras, B Lachance, W Foster, J Goudreault, L Archambault
Medical Physics 42 (12), 7011-7021, 2015
62015
US-guided EM tracked system for HDR brachytherapy: A first in-men randomized study for whole prostate treatment
MC Lavallee, A Cantin, S Aubin, M Lefebvre, AS Marrier, I Bouchard, ...
Brachytherapy 23 (1), 64-72, 2024
12024
PSOR3 Presentation Time: 11: 40 AM: The Role of CAPRA Score as a Predictor of Outcomes in High-Risk Prostate Cancer Patients Treated with EBRT Plus HDR Brachytherapy Boost: A …
B Morales, D Carignan, P Després, S Magnan, MA Froment, W Foster, ...
Brachytherapy 21 (6), S66-S67, 2022
2022
154: The Role of CAPRA Score as a Predictor of Outcomes in High-Risk Prostate Cancer Patients Treated with EBRT Plus HDR Brachytherapy Boost
E Vigneault, D Carignan, S Magnan, P Després, AG Martin, W Foster, ...
Radiotherapy and Oncology 174, S65, 2022
2022
From conception to clinical trial: IViST, the first multi-sensor-based platform for real-time In Vivo Source Tracking in HDR brachytherapy
HML Rosales, A Cantin, S Aubin, S Beddar, L Beaulieu
Journal of Physics: Conference Series 2167 (1), 012024, 2022
2022
PP25 Presentation Time: 4: 20 PM: In Vivo Dosimetry in Brachytherapy: A First Clinical Trial Implementation with a mPSD Detector
HML Rosales, A Cantin, S Aubin, D Tho, M Lefebvre, N Dufour, AG Martin, ...
Brachytherapy 20 (3), S22-S23, 2021
2021
PO-0209 Practical considerations on the use of EM tracking technology for clinical HDR brachytherapy
MC Lavallee, A Cantin, E Vigneault, W Foster, S Aubin, A Martin, ...
Radiotherapy and Oncology 158, S168-S169, 2021
2021
OC-0106 US-guided EM tracked system compared to OncentraProstate for HDR brachytherapy: a first in-men study
MC Lavallee, A Cantin, M Lefebvre, W Foster, S Aubin, AG Martin, ...
Radiotherapy and Oncology 158, S74-S75, 2021
2021
OC-0101 17 years' of EBRT plus HDR brachytherapy boost in high risk localized prostate cancer patients
E Vigneault, D Carignan, S Magnan, M Froment, W Foster, S Aubin, ...
Radiotherapy and Oncology 158, S69-S70, 2021
2021
OC-0065 Real-time electromagnetic guidance for GYN interstitial HDR brachytherapy: a proof-of-concept
A Cantin, M Lavallée, É Poulin, W Foster, L Beaulieu
Radiotherapy and Oncology 158, S49-S51, 2021
2021
14: Seventeen Years Experience of Ebrt Plus Hdr Brachytherapy Boost in High-Risk Localized Prostate Cancer Patients: A Competing Risks Analysis
D Carignan, P Després, S Magnan, MA Froment, W Foster, S Aubin, ...
Radiotherapy and Oncology 150, S9-S10, 2020
2020
From conception to clinical trial: IViST--the first multi-sensor-based platform for real-time In Vivo dosimetry and Source Tracking in HDR brachytherapy
HML Rosales, A Cantin, S Aubin, S Beddar, L Beaulieu
arXiv preprint arXiv:2006.08031, 2020
2020
From conception to clinical trial: IViST--the first multi-sensor-based platform for real-time In Vivo dosimetry and Source Tracking in HDR brachytherapy
HM Linares Rosales, A Cantin, S Aubin, S Beddar, L Beaulieu
arXiv e-prints, arXiv: 2006.08031, 2020
2020
IViST: A Platform for Real-Time In Vivo Source Tracking in HDR Brachytherapy
HL Rosales, J Johansen, A Cantin, G Kertzscher, L Archambault, ...
MEDICAL PHYSICS 46 (6), E494-E494, 2019
2019
Comparaison de trois méthodes de traitement adaptatives en IMRT: le cas du cancer de la prostate
A Cantin
2014
SU‐E‐T‐593: Comparison of Three IMRT Adaptive Methods: The Case of Prostate Cancer
A Cantin, N Octave, J Goudreault, W Foster, B Lachance, L Beaulieu, ...
Medical Physics 40 (6Part20), 342-342, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–17